Skip to main content
. 2022 Feb 25;12:3225. doi: 10.1038/s41598-022-07334-w

Figure 3.

Figure 3

Evaluating the predictive performance of this immune-related lncRNA signature on bladder cancer prognoses. (A) ROC curves of the immune-related lncRNA signature for bladder cancer subjects. The maximum inflection point was the cut-off point that was calculated with the AIC method. The AUC value was calculated for evaluating the predictive efficacy of this signature in bladder cancer prognoses. (B) The one-, three- and five-year ROC curves of this signature. (C) Calculating the risk score of each bladder cancer subject and distinguishing patients into high and low risk subgroups based on the cutoff value (vertical dotted line). Red: high risk and green: low risk. (D) Visualizing the distribution of survival status in high and low risk bladder cancer subjects. Red dots: alive and green dots: alive. Vertical dotted line represented the cutoff value of two subgroups. (E) Kaplan–Meier curves of overall survival between high and low risk patients.